Discovery of 2-(4-Acrylamidophenyl)-Quinoline-4-Carboxylic Acid Derivatives as Potent SIRT3 Inhibitors
In discovery of novel SIRT3 inhibitors for the treatment of cancer, a series of 2-(4-acrylamidophenyl)-quinoline-4-carboxylic acid derivatives were designed and synthesized. Among the derived compounds, molecule P6 exhibited SIRT3 inhibitory selectivity with IC50 value of 7.2 µM over SIRT1 (32.6 µM)...
Main Authors: | Qian Hui, Xueming Li, Wenli Fan, Congying Gao, Lin Zhang, Hongyu Qin, Liuya Wei, Lei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.880067/full |
Similar Items
-
The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification
by: Jingfang Yao, et al.
Published: (2022-04-01) -
Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage
by: Wang Y, et al.
Published: (2018-11-01) -
Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo
by: Xinyuan Xu, et al.
Published: (2024-03-01) -
SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
by: Huihuan Wang, et al.
Published: (2021-07-01) -
The Effect of Antiretroviral Therapy on SIRT1, SIRT3 and SIRT6 Expression in HIV-Infected Patients
by: Karolina Jurkowska, et al.
Published: (2022-02-01)